FLAGSTAFF, Ariz. & BOSTON--(BUSINESS WIRE)--(The Liver Meeting)—W.L. Gore & Associates (Gore) today announced a new prospective, randomized, multi-center study at the Annual Meeting of the American Association for the Study of Liver Diseases. The hypothesis of the study is that early intervention with the GORE® VIATORR® TIPS Endoprosthesis improves transplant-free survival when compared to large volume paracentesis in patients with cirrhosis and difficult to treat ascites. The study is expected to be the largest and most rigorous multi-disciplinary collaboration with hepatologists and interventional radiologists looking at early TIPS therapy. Gore expects the study to involve 150 subjects at more than 20 sites. The lead co-investigators are Thomas Boyer, MD, Chief of the Arizona Liver Institute and Ziv Haskal, MD, Professor and Director of the Vascular & Interventional Radiology at the University of Maryland Medical Center. Gore is launching an informational website at clinical.goremedical.com/earlytips/
